Sante Health Ventures
Venture capitalActively deployingAustin · 4 people tracked
Find your way into Sante Health Ventures
1,301 people in our graph share verified history with the Sante Health Ventures team — schools, employers, funds. One of them is your warm intro.
Fund manager profile
Sante Health Ventures is a venture fund manager based in Austin. SEC filings show 5 venture funds on record, most recently Sante Health Ventures V, LP ($300M offering) filed May 2025.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 4 people
from public directories
What they invest in
from 5 of 6 portfolio companiesBiotech ×4Healthtech ×2AI & Machine Learning ×1Digital Health ×1
HQs:United States×6
Investments · 6 tracked
founders shown can be your intro pathBy year:2025 · 12023 · 12022 · 12015 · 22014 · 16 dated
Lumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency.
BiotechHealthtechAustin, US
Richard John Hawkins(Executive Officer, Director)John C. McKew(President and Chief Scientific Officer)inPisit "Duke" Pitukcheewanont(Chief Medical Officer)inLori Lawley(Chief Financial Officer)inBrad Powers(Chief Compliance Officer and General Counsel)inCampbell Murray(Executive Chairman)in
Board seatKevin M. Lalande· per SEC Form D · $13M raise · filed May 2015
Co-investorsNew Enterprise Associates (NEA)Clarus VenturesDeerfield Management CompanySante VenturesWellcome Trust
BiotechAustin, US
Eric E. Poma(Executive Officer, Director)Jason S. Kim(Executive Officer)David R. Hoffmann(Director)David Hirsch(Director)David Valacer(Executive Officer)Harold Selick(Director)
Board seatKevin LalandeKevin M. Lalande· per SEC Form D · $90.7M raise · filed Jul 2023
Co-investorsExcel Venture Management
Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.
AI & Machine LearningBiotechDigital HealthMedford, US
Jerrold Rosenbaum(Director)inJacob Hooker(Executive Officer, Director)inPranav Tadi(Executive Officer)
BoardRyan Katz(Director)inRichard Simon(Director)
Board seatKevin Lalande· per SEC Form D · $58.5M raise · filed Jul 2025
Co-investorsBonaventure Equity, LLCHatteras Venture PartnersIter InvestmentsMission BiocapitalRoute 66 VenturesService Provider Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ChanRxClairity, Inc.Hospitalists Now
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companiesMolecular Templates · ad-hoc-news.de · Jun 2, 2026
Sensorium Therapeutics · finsmes.com · Aug 29, 2025
Fund performance · per public LP disclosures · 2
as of Sep 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Sante Health Ventures IVLPs: Pennsylvania Public School Employees' Retirement System | 2021 | — | 20.2% | 1.51x | — |
| Sante Health Ventures IIILPs: Pennsylvania Public School Employees' Retirement System | 2018 | — | 21.1% | 2.07x | 0.56x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- How many investments has Sante Health Ventures made?
- Sante Health Ventures has 6 tracked investments, including 1 dated in the last 24 months.
- Where is Sante Health Ventures located?
- Sante Health Ventures is headquartered in Austin, US.